Scientists find 'outlier' enzymes, potential new targets to treat diabetes, inflammation

(Scripps Research Institute) A team led by scientists at The Scripps Research Institute and the Salk Institute for Biological Studies has discovered two enzymes that appear to play a role in metabolism and inflammation--and might someday be targeted with drugs to treat type 2 diabetes and inflammatory disorders.